Texas Trainer Keeton Banned 16 Years, Fined $80,000 for Widespread Doping

Toby Keeton's career in Texas Quarter Horse racing came to a halt when the Texas Racing Commission handed him a 16-year suspension and an $80,000 fine, a ruling driven by positive drug tests from 23 horses in his barn during the 2024 Lone Star Park fall meet.

Twenty-two of those horses tested positive for carmoterol, a Class 1A bronchodilator capable of significantly enhancing respiratory performance. A 23rd horse tested positive for d-methamphetamine. The scale of the positives, spread across a single meet, led commissioners to treat the case as systematic rather than incidental, and the resulting sanctions stand as among the harshest in the state's regulatory history.

The commission's written decision, dated March 26, 2026, detailed sample-level findings and chain-of-custody verifications that underpinned each positive. The pattern across 23 horses at one meet gave regulators the evidentiary foundation to frame this not as an isolated oversight but as evidence of a deliberate and widespread program. The $80,000 fine accompanies additional procedural penalties outlined in the ruling letter.

For Quarter Horse racing in Texas, the implications stretch well beyond Keeton's barn. Class 1A substances occupy the most serious tier of prohibited materials under racing medication rules. Carmoterol's ability to markedly affect breathing capacity raises direct questions about the competitive fairness of races in which those horses participated, including purse distributions, placings, and the integrity of wagering results tied to those events. Owners and consignors affiliated with Keeton's operation now face the immediate task of re-licensing horses under different trainers, reallocating race entries, and managing the financial disruption that follows a barn shutdown of this scope.

The 16-year ineligibility strips Keeton of his ability to hold a Texas racing license for the foreseeable future, removing him from active stabling and training with immediate effect. His camp retains the right to appeal to the commission or to state courts, and legal counsel in high-dollar suspension cases typically pursues stays of enforcement while challenges proceed. Absent a successful appeal, however, the ruling leaves Keeton sidelined well into the 2040s.

Racing commissions across jurisdictions have faced sustained pressure to demonstrate rigorous enforcement following a series of high-profile medication scandals in recent years. This ruling signals that Texas regulators are prepared to reach for maximum penalties when evidence points to repeated violations across an entire stable. The case is expected to surface in future rule-making discussions around testing frequency, penalty guidelines, and the threshold at which individual violations become treated as systemic misconduct.